DOAJ Open Access 2022

Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study

Simon F. Thomsen Ellen C. Pritzier Chris D. Anderson Siri Juvik Nicolas V. Baust +3 lainnya

Abstrak

The AWARE (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation) study investigated outcomes in patients with chronic urticaria refractory to H1-antihistamine. The objective of the current study was to analyse the effects of treatment on patients’ symptoms and quality of life for a period of up to 2 years. Over the 2 years, there was clear improvement in the high rates of disease burden from baseline, as evidenced by lower scores for disease severity scales, better quality of life, and a decreasing rate of medical resource utilization. However, this is the result of treatment adherence to the guidelines in highly specialized Scandinavian urticaria centres, and has its basis in the relatively low treatment intensity and control at enrolment. There is a need for greater adherence to the treatment guidelines and better management of antihistamine-refractory chronic urticaria.

Topik & Kata Kunci

Dermatology

Penulis (8)

Simon F. Thomsen

Ellen C. Pritzier

Chris D. Anderson

Siri Juvik

Nicolas V. Baust

Rikke Dodge

Anna-Karin Dahlborn

Christian Vestergaard

Format Sitasi

APA MLA BibTeX

Thomsen, S.F., Pritzier, E.C., Anderson, C.D., Juvik, S., Baust, N.V., Dodge, R. et al. (2022). Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study. https://doi.org/10.2340/actadv.v102.1620

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.2340/actadv.v102.1620

Informasi Jurnal

Tahun Terbit: 2022
Sumber Database: DOAJ
DOI: 10.2340/actadv.v102.1620
Akses: Open Access ✓